跳至主要内容
临床试验/CTRI/2020/09/027622
CTRI/2020/09/027622已完成未知

Role of short term oral oestradiol in natural oestrogen deficient symptomatic COVID-19 patients-a Randomized Control Study

Dr Shikha seth0 个研究点目标入组 64 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Documented symptomatic(fever of 100.5°F or more or 38°C shortness of breath cough anosmia GI disturbances persisting myalgiaetc any one of them present).) COVID19 positive patients.
  • 2.Male 18-60 years of age
  • 3.Female 40-60 years of age with one year amenorrhoea.
  • 4.Ready to participate and provide informed consent.
  • 5.Patients enrolled shall not be the part of any other drug trial.

排除标准

  • 1.Currently receiving estrogen based hormonal therapy
  • 2.Abnormal genital bleeding
  • 3.Subjects with known past diagnosis of estrogen receptor positive breast cancer or endometrial cancer
  • 4.Pre-existing liver impairment (e.g. Hepatitis C, cirrhosis),heart disease, Any history of thromboembolic event including deep vein thrombosis or pulmonary emboli , History of stroke.
  • 5.Receiving anti epileptic therapy
  • 6.Subjects with severe COVID disease.
  • 7.Males on testosterone
  • 8.Those on steroids for any of their disease
  • 9.Patients enrolled in any other drug trial.

研究者

发起方
Dr Shikha seth

相似试验